| | | | | | | | | | | | | | | | | | | | | | |
Ownership Document
|
| Schema Version: X0508 |
| Document Type: 4 |
| Period of Report: 2/26/24 |
| Not Subject to Section 16: 0 |
| Issuer: |
| Issuer CIK: 1703057 |
| Issuer Name: AbCellera Biologics Inc. |
| Issuer Trading Symbol: ABCL |
| Reporting Owner: |
| Reporting Owner ID: |
| | Owner CIK: 1834412 |
| | Owner Name: Hansen Carl L. G. |
| Reporting Owner Address: |
| | Owner Street 1: C/O ABCELLERA BIOLOGICS INC |
| | Owner Street 2: 2215 YUKON STREET |
| | Owner City: VANCOUVER |
| | Owner State: A1 |
| | Owner ZIP Code: |
| | Owner State Description: BRITISH COLUMBIA, CANADA |
| Reporting Owner Relationship: |
| | Is Director? Yes |
| | Is Officer? Yes |
| | Is Ten Percent Owner? Yes |
| | Is Other? No |
| | Officer Title: Chief Executive Officer |
| Aff 10b5 One: 0 |
| Non-Derivative Table: |
| Non-Derivative Transaction: |
| | Security Title: |
| | | Value: Common Shares |
| | Transaction Date: |
| | | Value: 2/26/24 |
| | Transaction Coding: |
| | | Transaction Form Type: 5 |
| | | Transaction Code: M |
| | | Equity Swap Involved? No |
| | Transaction Timeliness: |
| | | Value: E |
| | Transaction Amounts: |
| | | Transaction Shares: |
| Value: 56,125 |
| | | Transaction Price Per Share: |
| Value: 2.70 |
| | | Transaction Acquired-Disposed Code: |
| Value: A |
| | Post-Transaction Amounts: |
| | | Shares Owned Following Transaction: |
| Value: 729,625 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: D |
| Non-Derivative Holding: |
| | Security Title: |
| | | Value: Common Shares |
| | Post-Transaction Amounts: |
| | | Shares Owned Following Transaction: |
| Value: 55,802,493 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: I |
| | | Nature of Ownership: |
| Value: See footnote |
| Footnote ID: F1 |
| Derivative Table: |
| Derivative Transaction: |
| | Security Title: |
| | | Value: Share option (right to buy) |
| | Conversion or Exercise Price: |
| | | Value: 2.70 |
| | Transaction Date: |
| | | Value: 2/26/24 |
| | Transaction Coding: |
| | | Transaction Form Type: 5 |
| | | Transaction Code: M |
| | | Equity Swap Involved? No |
| | Transaction Timeliness: |
| | | Value: E |
| | Transaction Amounts: |
| | | Transaction Shares: |
| Value: 56,125 |
| | | Transaction Price Per Share: |
| Value: 0 |
| | | Transaction Acquired-Disposed Code: |
| Value: D |
| | Exercise Date: |
| | | Footnote ID: F2 |
| | Expiration Date: |
| | | Value: 11/27/30 |
| | Underlying Security: |
| | | Underlying Security Title: |
| Value: Common Shares |
| | | Underlying Security Shares: |
| Value: 56,125 |
| | Post-Transaction Amounts: |
| | | Shares Owned Following Transaction: |
| Value: 8,428,598 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: D |
| Footnotes: |
| Footnote - F1: These shares are held by Thermopylae Holdings Ltd., which is an entity wholly owned by the reporting person. |
| Footnote - F2: The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date. |
| Remarks: |
| Owner Signature: |
| Signature Name: Tryn Stimart, attorney-in-fact |
| Signature Date: 2/27/24 |
